FDA
approval
· 2026-02-06
FDA Approved: TICAGRELOR — Original Application (Lifestar Pharma LLC)
Summary
The FDA approved Lifestar Pharma LLC's original ANDA for ticagrelor, a P2Y12 receptor inhibitor used to reduce thrombotic cardiovascular events in certain acute…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TICAGRELOR (TICAGRELOR)